Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Evidence synthesis · Safety review

Delayed gastric emptying, residual gastric content and procedural sedation

Does treatment with a glucagon-like peptide-1 receptor agonist increase residual gastric content at the time of elective procedural sedation?

Document identifier
CEI-ES-026
Series
Evidence synthesis
Version
2.2
Published
13 Sep 2024
Last reviewed
13 Feb 2025
Next review
13 Aug 2026
Identifier
10.71829/cei.syn.26
Certainty
Low
Cycle
2024 Q3
Review type
Safety review
Search executed
18 Jul 2024

§1Abstract

§1.1Review question

Does treatment with a glucagon-like peptide-1 receptor agonist increase residual gastric content at the time of elective procedural sedation?

§1.2PICO frame

Table 1. The registered PICO frame. Any change made after protocol registration is recorded in the amendment log at §5 and is identified there as post hoc.

ElementAs registered
PopulationAdults presenting for elective endoscopy or surgery under sedation or general anaesthesia.
InterventionCurrent treatment with a glucagon-like peptide-1 receptor agonist.
ComparatorNo such treatment.
OutcomesResidual gastric content on ultrasound or at endoscopy; pulmonary aspiration; procedure cancellation.

§1.3Method in brief

A review of harms, in which the absence of an event in a trial of conventional size is treated as uninformative rather than as reassurance. The protocol was registered with the Institute's secretariat before the search was executed. The search was run on 18 July 2024 across 8 sources and is reproduced in full at §2. Screening, extraction and certainty assessment were performed independently by two members of the secretariat with disagreement resolved by a third.

§1.4Conclusion

Low certainty evidence, almost entirely observational, indicates that residual gastric content is found more often in treated patients after a standard fasting period. Pulmonary aspiration is rare enough that the observational evidence cannot establish whether the increase in residual content translates into an increase in aspiration. Professional guidance has changed on the basis of the residual-content finding, which the Institute records as a reasonable precautionary response to low certainty evidence and labels as such rather than presenting it as an evidence-based recommendation.

§1.5Limitations

§1.6Consultation

This review was released for public comment before ratification. Draft safety review: delayed gastric emptying and procedural sedation received 15 submissions. Amendments arising are recorded in the amendment log and are traceable to a numbered submission.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.